495 related articles for article (PubMed ID: 18625270)
1. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
2. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the internal ribosome entry site (IRES)-mediated translation of the hepatitis C virus: critical role of binding of the stem-loop IIId domain of IRES and the viral core protein.
Shimoike T; Koyama C; Murakami K; Suzuki R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Feb; 345(2):434-45. PubMed ID: 16297950
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
5. Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).
Nulf CJ; Corey D
Nucleic Acids Res; 2004; 32(13):3792-8. PubMed ID: 15263060
[TBL] [Abstract][Full Text] [Related]
6. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
7. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
9. A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.
Caldarelli SA; Mehiri M; Di Giorgio A; Martin A; Hantz O; Zoulim F; Terreux R; Condom R; Patino N
Bioorg Med Chem; 2005 Oct; 13(20):5700-9. PubMed ID: 16061387
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of translation initiation on hepatitis C virus RNA.
Nomoto A; Tsukiyama-Kohara K; Kohara M
Princess Takamatsu Symp; 1995; 25():111-9. PubMed ID: 8875615
[TBL] [Abstract][Full Text] [Related]
11. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
12. Yellow fever 5' noncoding region as a potential element to improve hepatitis C virus production through modification of translational control.
Malet I; Wychowski C; Huraux JM; Agut H; Cahour A
Biochem Biophys Res Commun; 1998 Dec; 253(2):257-64. PubMed ID: 9878525
[TBL] [Abstract][Full Text] [Related]
13. Cap and polyA tail enhance translation initiation at the hepatitis C virus internal ribosome entry site by a discontinuous scanning, or shunting, mechanism.
Wiklund L; Spångberg K; Goobar-Larsson L; Schwartz S
J Hum Virol; 2001; 4(2):74-84. PubMed ID: 11437317
[TBL] [Abstract][Full Text] [Related]
14. Interfering with hepatitis C virus IRES activity using RNA molecules identified by a novel in vitro selection method.
Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
Biol Chem; 2005 Feb; 386(2):183-90. PubMed ID: 15843163
[TBL] [Abstract][Full Text] [Related]
15. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
Krüger M; Beger C; Welch PJ; Barber JR; Manns MP; Wong-Staal F
Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
[TBL] [Abstract][Full Text] [Related]
16. Human ribosomal protein L18a interacts with hepatitis C virus internal ribosome entry site.
Dhar D; Mapa K; Pudi R; Srinivasan P; Bodhinathan K; Das S
Arch Virol; 2006 Mar; 151(3):509-24. PubMed ID: 16195786
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA.
Honda M; Ping LH; Rijnbrand RC; Amphlett E; Clarke B; Rowlands D; Lemon SM
Virology; 1996 Aug; 222(1):31-42. PubMed ID: 8806485
[TBL] [Abstract][Full Text] [Related]
18. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
19. Complete 5' noncoding region is necessary for the efficient internal initiation of hepatitis C virus RNA.
Fukushi S; Katayama K; Kurihara C; Ishiyama N; Hoshino FB; Ando T; Oya A
Biochem Biophys Res Commun; 1994 Mar; 199(2):425-32. PubMed ID: 8135783
[TBL] [Abstract][Full Text] [Related]
20. Targeting hepatitis C virus translation: stopping HCV where it starts.
Jubin R
Curr Opin Investig Drugs; 2003 Feb; 4(2):162-7. PubMed ID: 12669376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
